Atherothrombosis and Coronary Artery Disease

Published nearly a decade after the first, this second edition incorporates extensive revisions and ten new chapters--on the human genome and genetic basis of artherothrombotic disease; the molecular basis of vasculogenesis, angiogenesis and arteriogenesis; mouse models of lipoprotein metabolism and atherothrombosis; the development of high-and low-risk coronary and noncoronary artherothrombotic plaques; and new imaging technologies. Coverage also includes non-surgical and surgical interventions of peripheral and carotid disease, and behavioral and alternative medicine in atherothrombosis treatments. The chapters are signed and include an outline, keywords list, and text in an outline format with headers in red type for clarity. Fuster is with several medical institutions in New York City and is president of the World Heart Federation. His co-editors are Eric J. Topol at the Cleveland Clinic Foundation and Elizabeth G. Nabel at the National Institutes of Health in Bethesda. Most of the over 200 contributors are affiliated with medical schools and hospitals in the US. Annotation c2004 Book News, Inc., Portland, OR (booknews.com)